As I mentioned yesterday, the medical device tax that went into effect last January is just one of the many insidious job-killing measures contained within ObamaCare, but it is an especially terrible one. The 2.3 percent excise tax is meant to raise a handsome $30 billion to pay for ObamaCare over the next decade, except that, added bonus: It’s going to stifle innovation and competition in an industry that provides all manner of life-saving medical devices, from MRIs to pacemakers to blood tubes. And this hasn’t just been a Republican refrain, by the way. Thursday night, the Senate voted overwhelmingly...
